Login to Your Account



Redx to Add Metabolic Disease Unit with Help from UK's RGF

By Nuala Moran
Staff Writer

Wednesday, July 17, 2013
LONDON – Redx Pharma Ltd. is motoring toward the launch of a third research division, securing a conditional offer from the UK government's Regional Growth Fund (RGF) for a unit specializing in metabolic disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription